Additionally, the research assessed regional tau accumulation in brain areas known for their vulnerability in early Alzheimer’s disease stages, specifically the MTL and DMN (Huijbers et al., 2019; Gardini et al., 2021), and incorporated groups of brain regions targeted by tau pathology and how it spreads in accordance with Braak staging. The gene discussed is MAPT; the disease is Alzheimer disease.